Research Grant Opportunities
PPMD’s research program is to drive translation of basic science and understanding of the disease into meaningful therapies for all individuals with Duchenne.
PPMD is interested in how to effectively and safely expedite the clinical trial process toward treatments and cure.
PPMD’s Grant Application Process
PPMD seeks out opportunities to invest in and leverage additional funds to drive progress in identifying gaps in research and facilitating translational opportunities.
Applications to PPMD are reviewed by a combination of:
- Our Scientific Advisory Committee
- Ad hoc reviewers, when very specific expertise is needed
- TREAT-NMD’s Advisory Committee on Therapeutics (TACT) – PPMD has an informal agreement with TACT to review some projects
Applications to PPMD’s Research Grants program should focus on new ideas or studies that are highly relevant to Duchenne muscular dystrophy therapy development and might impact this generation of individuals with Duchenne.
PPMD funds meritorious studies in academic laboratories and for-profit companies done by professional, qualified investigators who hold a MD, PhD, or equivalent degree, and have access to institutional resources necessary to conduct the proposed research project. Awardees will successfully complete identified project-based milestones, submit records of appropriate institutional/federal regulatory requirements, and present timely publication of project results. Applications will be reviewed on a case-by-case basis and must fit PPMD’s 2018 research grants initiatives.
Current Grant Opportunities & Deadlines
There are no open grant opportunities at this time.
For more information please contact Eric Camino, VP of Research & Clinical Innovation, at email@example.com.